Source: Antimicrobial Agents Chemotherapy. Unidade: FCF
Subjects: STAPHYLOCOCCUS, RNA RIBOSSÔMICO
ABNT
ALMEIDA, Lara Mendes de et al. Linezolid resistance in Brazilian Staphylococcus hominis strains is associated with L3 and 23S rRNA ribosomal mutations. Antimicrobial Agents Chemotherapy. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.1128/AAC.00437-13. Acesso em: 26 set. 2024. , 2013APA
Almeida, L. M. de, Araújo, M. R. E. de, Sacramento, A. G., Pavez, M., Souza, A. G. de, Rodrigues, F., et al. (2013). Linezolid resistance in Brazilian Staphylococcus hominis strains is associated with L3 and 23S rRNA ribosomal mutations. Antimicrobial Agents Chemotherapy. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.1128/AAC.00437-13NLM
Almeida LM de, Araújo MRE de, Sacramento AG, Pavez M, Souza AG de, Rodrigues F, Gales AC, Lincopan N, Sampaio JLM, Mamizuka EM. Linezolid resistance in Brazilian Staphylococcus hominis strains is associated with L3 and 23S rRNA ribosomal mutations [Internet]. Antimicrobial Agents Chemotherapy. 2013 ; 57( 8): 4082-4083.[citado 2024 set. 26 ] Available from: https://doi.org/10.1128/AAC.00437-13Vancouver
Almeida LM de, Araújo MRE de, Sacramento AG, Pavez M, Souza AG de, Rodrigues F, Gales AC, Lincopan N, Sampaio JLM, Mamizuka EM. Linezolid resistance in Brazilian Staphylococcus hominis strains is associated with L3 and 23S rRNA ribosomal mutations [Internet]. Antimicrobial Agents Chemotherapy. 2013 ; 57( 8): 4082-4083.[citado 2024 set. 26 ] Available from: https://doi.org/10.1128/AAC.00437-13